Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO Regimens in Primary Immune Thrombocytopenia (ITP)
NCT04089267Phase 4Completed
- Sponsor
- 3SBio
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human thrombopoietin in primary immune thrombocytopenia (ITP), sponsored by 3SBio. Started Dec 2016; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04089267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04089267.